Home › Trial NCT06947226
A Clinical Study of 9MW2821 Monotherapy or Combined With Other Anticancer Therapy in Advanced Solid Tumors
- Trial IDNCT06947226
- StatusNot Yet Recruiting
- PhasePhase 1/2
- Study typeInterventional
- SponsorMabwell (Shanghai) Bioscience Co., Ltd.
- Enrollment188
- Start date2025-04
- ConditionsSolid Tumors
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.